Evidence map›Paper›PMID 36745712›Full record

ArticleBiomacromolecules2023

Multicolor Light-Induced Immune Activation via Polymer Photocaged Cytokines.

Lacey A Birnbaum, Emily C Sullivan, Priscilla Do, Biaggio Uricoli, Sunil S Raikar, Christopher C Porter, Curtis J Henry, Erik C Dreaden

Open access · hybridFull text read
In one paragraph

Article in Biomacromolecules, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Lacey A BirnbaumCoulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia 30332, United States.
Emily C SullivanMolecular and Systems Pharmacology Graduate Program, Emory University School of Medicine, Atlanta, Georgia 30307, United States.
Priscilla DoCoulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia 30332, United States.ORCID 0000-0002-8908-9245
Biaggio UricoliCoulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia 30332, United States.
Sunil S RaikarWinship Cancer Institute of Emory University, Atlanta, Georgia 30322, United States.
Christopher C PorterWinship Cancer Institute of Emory University, Atlanta, Georgia 30322, United States.
Curtis J HenryWinship Cancer Institute of Emory University, Atlanta, Georgia 30322, United States.
Erik C DreadenCoulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia 30332, United States.ORCID 0000-0002-4954-8443
Emory University · USGeorgia Institute of Technology · US

Funding

T32 Research Training Program in ImmunoEngineeringT32EB021962 · NIBIB · GEORGIA INSTITUTE OF TECHNOLOGY · PI JULIA E BABENSEE · 2017 to 2026
$1.9M
Gamma delta T-cell immunotherapy for T-cell acute lymphoblastic leukemiaK08CA248962 · NCI · EMORY UNIVERSITY · PI RAIKAR, SUNIL SUDHIR · 2020 to 2024
$1.1M
NCI NIH HHS K08 CA248962NIBIB NIH HHS T32 EB021962
6 · The paper itself

Abstract

Cytokines act as potent, extracellular signals of the human immune system and can elicit striking treatment responses in patients with autoimmune disease, tissue damage, and cancer. Yet, despite their therapeutic potential, recombinant cytokine-mediated immune responses remain difficult to control as their administration is often systemic, whereas their intended sites of action are localized. To address the challenge of spatially and temporally constraining cytokine signals, we recently devised a strategy whereby recombinant cytokines are reversibly inactivated via chemical modification with photo-labile polymers that respond to visible LED light. Extending this approach to enable both in vivo and multicolor immune activation, here we describe a strategy whereby cytokines appended with heptamethine cyanine-polyethylene glycol are selectively re-activated ex vivo using tissue-penetrating near-infrared (NIR) light. We show that NIR LED light illumination of caged, pro-inflammatory cytokines restores cognate receptor signaling and potentiates the activity of T cell-engager cancer immunotherapies ex vivo. Using combinations of visible- and NIR-responsive cytokines, we further demonstrate multiwavelength optical control of T cell cytolysis ex vivo, as well as the ability to perform Boolean logic using multicolored light and orthogonally photocaged cytokine pairs as inputs and T cell activity as outputs. Together, this work demonstrates a novel approach to control extracellular immune cell signals using light, a strategy that in the future may improve our understanding of and ability to treat cancer and other diseases.

Indexed as

CytokinesNeoplasmsHumansImmunologic FactorsPolyethylene GlycolsPolymersCytokinesImmunologic FactorsPolyethylene GlycolsPolymers

Identifiers

PMID36745712
PMCPMC10015458
OpenAlexW4319303676

What Socratic holds

Textfull text, public
LicenceCC BY
measurements read26
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.